VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Post by PushSensor1on May 02, 2017 4:14pm

129 Views

Post# 26194495

why would any one pay more that the pp price ....

it was priced at 32 and a discount for a reason....selling new ultarsound system wont be easy

deadddddddd.....especially if new software gets created by samsung or ge

good luck with vms plus ..im bettig ge or samsung will get th esoftware needed to get data equired to asses the heart

lets face it how can samsung not measure a 5 d image....my lord

Bullboard Posts

AI companies to invest in